Meta-analysis: The effect of supplementation with lactoferrin on eradication rates and adverse events during helicobacter pylori eradication therapy

Helicobacter

Volumn 14, Issue 2, 2009, Pages 119-127

  Zou, Jian ^a   Dong, Jie ^a   Yu, Xiao Feng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Eradication; H. pylori; Lactoferrin; Side effects

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; ESOMEPRAZOLE; LACTOFERRIN; LEVOFLOXACIN; PLACEBO; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; TINIDAZOLE;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DIARRHEA; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TASTE DISORDER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; DIETARY SUPPLEMENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOFERRIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

HELICOBACTER PYLORI;

EID: 62149096035     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00666.x     Document Type: Article

References (40)

1. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002 16 : 3 15.
2. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990 335 : 1233 5.
3. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993 88 : 1870 5.
4. Boot H, de Jong D, van Heerde P, et al. Role of Helicobacter pylori eradication in high-grade MALT lymphoma. Lancet 1995 346 : 448 9.
5. Malfertheiner P. Me'graud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 2002 16 : 167 80.
6. Perri F, Qasim A, Marras L, et al. Treatment of Helicobacter pylori infection. Helicobacter 2003 8 : 53 60.
7. Kihira K, Satoh K, Saifuku K, et al. Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2000 14 : 1083 7.
8. Neville PM, Barrowclough S, Crocombe W, et al. Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients. Dig Liver Dis 2001 33 : 131 4.
9. Lee JM, Breslin NP, Hyde DK, et al. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999 13 : 489 96.
10. Huang JQ, Hunt RH. Treatment after failure. The problem of "non-responders". Gut 1999 45 : 140 4.
11. Hunt RH. Eradication of Helicobacter pylori infection. Am J Med 1996 100 : 42 51.
12. Guslandi M. Review article: alternative antibacterial agents for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001 15 : 1543 7.
13. Baker EN, Anderson BF, Baker HM, et al. Structure, function and flexibility of human lactoferrin. Int J Biol Macromol 1991 13 : 122 9.
14. Ellison RT. The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol 1994 357 : 71 90.
15. Dial EJ, Hall LR, Serna H, et al. Antibiotic properties of bovine lactoferrin in the host infected with Helicobacter pylori. Dig Dis Sci 1998 43 : 2750 6.
16. Dial EJ, Lichtenberger LM. Effect of lactoferrin on Helicobacter felis induced gastritis. Biochem Cell Biol 2002 80 : 113 7.
17. de Bortoli N, Leonardi G, Ciancia E, et al. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007 102 : 951 6.
18. Zullo A, de Francesco V, Scaccianoce G, et al. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. Dig Liver Dis 2007 39 : 806 10.
19. Tursi A, Elisei W, Brandimarte G, et al. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 2007 13 : 187 90.
20. Di Mario F, Aragona G, Dal Bó N, et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther 2006 23 : 1235 40.
21. Zullo A, de Francesco V, Scaccianoce G, et al. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study. Dig Liver Dis 2005 37 : 496 500.
22. Di Mario F, Dal Bó N, Aragona G, et al. Efficacy of bovine lactoferrin for Helicobacter pylori eradication: results of a multicenter study. Helicobacter 2004 9 : 568.
23. Di Mario F, Dal Bó N, Aragona G, et al. Bovine lactoferrin as rescue treatment for Helicobacter pylori infection: results of a multicenter study. Helicobacter 2004 9 : 569.
24. Di Mario F, Aragona G, Dal Bò N, et al. Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol 2003 36 : 396 8.
25. Di Mario F, Aragona G, Dal Bò N, et al. Use of bovine lactoferrin for Helicobacter pylori eradication. Dig Liver Dis 2003 35 : 706 10.
26. Altintas E, Sezgin O, Ulu O, et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World J Gastroenterol 2004 10 : 1656 8.
27. Sanchez L, Calvo M, Brock J. Biological role of lactoferrin. Arch Dis Child 1992 67 : 657 61.
28. Illingworth D, Walter K, Griffiths P, et al. Siderophore production and iron-regulated envelope proteins of Helicobacter pylori. Zentralbl Bakteriol 1993 280 : 113 9.
29. Singh PK, Parsek MR, Greenberg EP, et al. A component of innate immunity prevents bacterial biofilm development. Nature 2002 417 : 552 5.
30. Baldwin DA, Jenny ER, Aisen P. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J Biol Chem 1984 259 : 13391 4.
31. Wada T, Aiba Y, Shimizu K, et al. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scand J Gastroenterol 1999 34 : 238 43.
32. Mann DM, Romm E, Migliorini M. Delineation of the glycosaminoglycan binding site in the human inflammatory response protein lactoferrin. J Biol Chem 1994 269 : 23661 7.
33. Zhang GH, Mann DM, Tsai CM. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun 1999 67 : 1353 8.
34. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999 67 : 3267 75.
35. Jones EM, Smart A, Bloomberg G, et al. Lactoferrin a new antimicrobial peptide. J Appl Bacteriol 1994 77 : 208 14.
36. Bell GD, Powell K, Burridge SM, et al. Experience with "triple" anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992 6 : 427 35.
37. Di Mario F, Dal B'o N, Aragona G, et al. Efficacy of bovine lactoferrin for Helicobacter pylori eradication: results of a multicenter study. Gut 2004 53 (Suppl. VI A123.
38. Borody TJ, Ashman O. Lactoferrin: milking ulcers? Dig Liver Dis 2003 35 : 691 3.
39. Mielke S, Reddy R, Osato MS, et al. Direct activity of recombinant human lactoferrin against Helicobacter pylori. J Clin Microbiol 1996 34 : 2593 4.
40. Dial EJ, Romero JJ, Headon DR, et al. Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice. J Pharm Pharmacol 2000 52 : 1541 6.